Abstract CT204: Increasing Tumor Treating Fields dose at the tumor bed improves survival: Setting a framework for TTFields dosimetry based on analysis of the EF-14 Phase III trial in newly diagnosed glioblastoma

Authors: Matthew T. Ballo, Noa Urman, Ze'ev Bomzon, Gitit Lavy-Shahaf, Steven Toms

Published: 2019-08-07

DOI: 10.1158/1538-7445.am2019-ct204

Source: Full article